Autoimmune/inflammatory syndrome (ASIA) induced by biomaterials injection other than silicone medical grade

Lupus

Volumn 21, Issue 12, 2012, Pages 1326-1334

  Alijotas Reig, J ^a,b   Garcia Gimenez, V ^c,d   Llurba, E ^a,e   Vilardell Tarres M ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Universitat Autonoma   (Spain)

^c Europa Medical Centre   (Spain)

^d Spanish Society of Medicine and Cosmetic Surgery ^*  (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Acrylamides; adjuvant; autoimmune diseases; bioimplants; granuloma; hyaluronic acid; methacrylate

Indexed keywords

ALLOPURINOL; BISPHOSPHONIC ACID DERIVATIVE; CETIRIZINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; METHOTREXATE; POLYACRYLAMIDE; POLYLACTIC ACID; PREDNISONE; SILICONE;

ADJUVANT DISEASE; ANCA ASSOCIATED VASCULITIS; ANGIONEUROTIC EDEMA; ARTHRALGIA; ARTHRITIS; ARTICLE; AUTOIMMUNE INFLAMMTORY SYNDROME; AUTOINFLAMMATORY DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG MEGADOSE; FATIGUE; FEMALE; FEVER; FOLLOW UP; HUMAN; HYPOCOMPLEMENTEMIA; IMMUNOSUPPRESSIVE TREATMENT; JAW PAIN; LIVEDO RETICULARIS; LOW DRUG DOSE; LYMPHADENOPATHY; MALAISE; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MYALGIA; PANNICULITIS; PNEUMONIA; POLYARTHRITIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RADICULOPATHY; RASH; REMISSION; RETROSPECTIVE STUDY; SARCOIDOSIS; SJOEGREN SYNDROME; SKIN INDURATION; VITAMIN SUPPLEMENTATION;

ACRYLAMIDES; AUTOIMMUNE DISEASES; BIOCOMPATIBLE MATERIALS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; INFLAMMATION; INJECTIONS; MALE; METHACRYLATES; PROSTHESES AND IMPLANTS; RETROSPECTIVE STUDIES; SPAIN; SYNDROME;

EID: 84867019396     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312458838     Document Type: Article

References (39)

1. De Boulle K. Management of complications after implantation of fillers. J Cosmet Dermatol. 2004 ; 3: 2-15
2. Ellis DA, Makdessian AS, Brown DJ. Survey of future injectables. Facial Plast Surg Clin North Am. 2001 ; 9: 405-411
3. American Society of Plastic Surgery. Statistics of 2010, http://www.surgery.org/site/default/stats2010-1.pdf (2010, accessed 01 August 2011)
4. Frank PJ. Cosmetic symposium: Restylane. The Dermatologic Society of Greater New York, http://www.dersociety.org/default.asp?id=3&aui=sa&aid= 35 (2005, accessed 2 February 2005)
5. Engelman DE, Bradley B, Goldberg DJ. Dermal fillers: complications and informed consent. J Cosmet Laser Ther. 2005 ; 7: 29-32
6. Andre P, Lowe NJ, Parc A, Clerici TH, Zimmermann U. Adverse reactions to dermal fillers: a review of European experiences. J Cosmet Laser Ther. 2005 ; 7: 171-176
7. Duffy DM. Complications of fillers: overview. Dermatol Surg. 2005 ; 31: 1626-1633
8. Alijotas-Reig J, Garcia-Gimenez V. Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long-term follow-up and review of the literature. J Eur Acad Dermatol Venereol. 2008 ; 22: 50-61
9. Alijotas-Reig J, Garcia-Gimenez V, Miró-Mur F, Vilardell-Tarés M. Delayed immune-mediated adverse effects of polyalkylimide dermal fillers. Arch Dermatol. 2008 ; 144: 637-642
10. Bergeret-Galley C. Comparison of resorbable soft tissue fillers. Aesthetic Surg J. 2004 ; 24: 33-46
11. Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Adjuvants and autoimmunity. Lupus. 2009 ; 19: 1217-1225
12. Miyoshi K, Miyaoka T, Kobayashi Y, Itakura T, Hihijo K, Higashibara M. Hypergammaglobulinemia by prolonged adjuvanticity in man: disorders developed after augmentation mammoplasty. Ijishimpo. 1964 ; 22: 9-14
13. Miyoshi K, Shiragami H, Yoshida K. Adjuvant disease of man. Clin Immunol (Tokyo). 1973 ; 5: 785-794
14. Shoenfeld Y, Agmon-Levin N. 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011 ; 36: 4-8
15. Miró-Mur F, Hindié M, Kandhaya-Pillai R, Tobajas V, Schwartz S, Alijotas-Reig J. Medical-grade silicone induces release of proinflammatory cytokines in peripheral blood mononuclear cells without activating T cells. J Biomed Mater Res B Appl Biomater. 2009 ; 90B: 510-520
16. Alijotas-Reig J, Hindié M, Kandhaya-Pillai R, Miró-Mur F. Bioengineered hyaluronic acid elicited a non-antigenic T cell activation: implications from cosmetic medicine and surgery to nanomedicine. J Biomed Mater Res A. 2010 ; 95A: 180-190
17. Vera-Lastra O, Medina G, Cruz-Dominguez MP, et al. Human adjuvant disease induced by foreign substances: a new model of ASIA (Shoenfeld's syndrome). Lupus. 2012 ; 21: 128-135
18. Agmon-Levin N, Shoenfeld Y. Chronic fatigue syndrome with autoantibodies - the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant. Autoimmun Rev. 2008 ; 8: 52-55
19. Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg. 2005 ; 29: 34-48
20. Pons-Guiraud A. Actualisation des effets secundaires des produits de comblements des rides. Nouv Dermatol. 2003 ; 22: 205-210
21. Inmunologia. Roitt I Brostoff J Male D, ed. Barcelona: Gower Medical Publishing Ltd, ; 1986 :
22. Alijotas-Reig J. Vasculitis related to non-animal hyaluronic acid skin filler injections [Letter]. Dermatol Surg. 2010 ; 36: 272-273
23. Hirsch RJ, Stier M. Complications of soft tissue augmentation. J Drug Dermatol. 2008 ; 7: 841-845
24. Christen U, von Herrath G. Infections and autoimmunity. Good or bad? J Immunol. 2005 ; 174: 7481-7486
25. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003 ; 349: 1526-1533
26. Rose NR. Autoimmunity, infection and adjuvants. Lupus. 2010 ; 19: 354-358
27. Raschi E, Borghi MO, Grossi C, Broggini V, Pierangeli S, Meroni PL. Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome. Lupus. 2008 ; 17: 937-942
28. Chen K, Huang J, Gong W, Iribarren P, Dunlop NM, Wang JM. Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol. 2007 ; 26: 1271-1285
29. James DG, Williams WJ Major problems in internal medicine. Smith LLH, ed. Philadelphia: W.B. Saunders Co ; 1985: 1-254.
30. Sánchez O, Rodríguez-Sureda V, Domínguez C, et al. Study of biomaterial-induced macrophage activation, cell-mediated immune response and molecular oxidative damage in patients with dermal bioimplants. Immunobiol. 2012 ; 217: 44-53
31. Requena C, Izquierdo MJ, Navarro M, Martinez A, Vilata JJ, Botella R. Adverse reactions to injectable aesthetic microimplants. Am J Dermapathol. 2001 ; 23: 197-202
32. Cervera R. 'ASIA': a new systemic autoimmune syndrome?. Lupus. 2011 ; 20: 665-666
33. Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Adjuvants and immunity. Lupus. 2009 ; 18: 1217-1225
34. Tabuenca JM. Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet. 1981 ; 2: 567-568
35. Moya C, Antó JM, Taylor AJ. Outbreak of organising pneumonia in textile printing sprayers. Collaborative Group for the Study of Toxicity in Textile Aerographic Factories. Lancet. 1994 ; 344: 498-502
36. Mosca M, Neri R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol. 1999 ; 17: 585-589
37. Mosca M, Baldini C, Bombardieri S. Undifferentiated connective tissue diseases in 2004. Clin Exp Rheumatol. 2004 ; 22 (3 Suppl 33). S14 - S18
38. Brody GS, Conway DO, Deapen DM, Fisher JC, Hochberg MC, LeRoy EC. Consensus statement on the relationship of breast implants to connective tissue disorders. Plast Reconstr Surg. 1992 ; 90: 1102-1105
39. Caruso C, Candore G, Colonna Romano G, et al. HLA, aging and longevity: a critical reappraisal. Hum Immunol. 2000 ; 61: 942-949